Related Experiment Videos
Chronic active hepatitis. Experience from a Norwegian reference hospital during a decade
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1985
Summary
This study followed 90 chronic active hepatitis (CAH) patients, finding immunosuppressive therapy often necessary but difficult to discontinue. Many patients required reinstitution of treatment, highlighting the chronic nature of CAH.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Chronic active hepatitis (CAH) is an inflammatory liver disease with significant morbidity.
- Etiologies of CAH include viral infections and drug toxicity, but many cases are idiopathic.
Purpose of the Study:
- To investigate the long-term outcomes and treatment responses in a cohort of hospitalized patients with chronic active hepatitis.
Main Methods:
- Retrospective analysis of 90 hospitalized CAH patients diagnosed between 1971-1980.
- Follow-up until death or end of 1981, with assessment of etiology, complications, and response to immunosuppressive therapy.
Main Results:
- 28% of patients died, primarily from liver disease. 62% experienced complications of portal hypertension.
- 89% showed pronounced biochemical activity, and 93% received immunosuppressive therapy (corticosteroids +/- azathioprine).
- Treatment withdrawal was frequently unsuccessful, with 35/45 patients requiring reinstitution of therapy.
Conclusions:
- Chronic active hepatitis is a severe condition with high mortality and morbidity.
- Immunosuppressive therapy is often required but challenging to discontinue, indicating the chronic and relapsing nature of the disease.